Frequency and Nature of Generic "Design Around" of Brand‐Name Patents in the United States.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 190, doi. 10.1002/cpt.3659
- By:
- Publication type:
- Article
Works matching DE "DRUG patents"
Results: 437
1
2
An assessment of Canada's revised Patented Medicines (Notice of Compliance) Regulations.
- Published in:
- Journal of Generic Medicines, 2025, v. 21, n. 2, p. 52, doi. 10.1177/17411343251327092
- By:
- Publication type:
- Article
3
Revisiting Patent Linkage.
- Published in:
- Texas Intellectual Property Law Journal, 2025, v. 33, n. 3, p. 291
- By:
- Publication type:
- Article
4
Regulatory Property: The New IP.
- Published in:
- Columbia Journal of Law & the Arts, 2016, v. 40, n. 1, p. 53
- By:
- Publication type:
- Article
5
Statistical and regulatory considerations in assessments of interchangeability of biological drug products.
- Published in:
- European Journal of Health Economics, 2014, v. 15, p. 5, doi. 10.1007/s10198-014-0589-1
- By:
- Publication type:
- Article
6
State Responsibility for Access and Availability of Patented Drugs for Public Health.
- Published in:
- Yuridika, 2023, v. 38, n. 2, p. 219, doi. 10.20473/ydk.v38i2.43007
- By:
- Publication type:
- Article
7
Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines.
- Published in:
- Global & Regional Health Technology Assessment, 2022, v. 9, n. 1, p. 68, doi. 10.33393/grhta.2022.2366
- By:
- Publication type:
- Article
8
Abstracts.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, p. 3, doi. 10.1111/bcpt.13542
- Publication type:
- Article
9
Trends in the development of human stem cell-based non-animal drug testing models.
- Published in:
- Korean Journal of Physiology & Pharmacology, 2020, v. 24, n. 6, p. 441, doi. 10.4196/kjpp.2020.24.6.441
- By:
- Publication type:
- Article
10
Probiotics for the Management of Infectious Diseases: Reviewing the State of the Art.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.877142
- By:
- Publication type:
- Article
11
Australia and Western Pacific.
- Published in:
- Journal of Global Health, 2013, v. 3, n. 2, p. 2, doi. 10.7189/jogh.03.020201
- Publication type:
- Article
12
India.
- Published in:
- Journal of Global Health, 2013, v. 3, n. 1, p. 9, doi. 10.7189/jogh.03.010201
- Publication type:
- Article
13
The Tragedy of the Anticommons: A Concise Introduction and Lexicon.
- Published in:
- Modern Law Review, 2013, v. 76, n. 1, p. 6, doi. 10.1111/1468-2230.12000
- By:
- Publication type:
- Article
14
The Pharmaceutical Access Act: An Administrative Eminent Domain Solution to High Drug Prices.
- Published in:
- California Law Review, 2018, v. 106, n. 6, p. 2023, doi. 10.15779/Z38V97ZR9S
- By:
- Publication type:
- Article
15
Tailored Treatment, Tailored Enforcement: Protecting Innovation in Personalized Medicine from a Patent-Protection Loophole.
- Published in:
- George Washington Law Review Arguendo, 2016, v. 84, n. 2, p. 480
- By:
- Publication type:
- Article
16
The Spectacular Generic: Pharmaceuticals and the Simipolitical in Mexico.
- Published in:
- 2024
- By:
- Publication type:
- Book Review
17
Privileged Scaffold Analysis of Natural Products with Deep Learning-based Indication Prediction Model.
- Published in:
- Molecular Informatics, 2020, v. 39, n. 11, p. 1, doi. 10.1002/minf.202000057
- By:
- Publication type:
- Article
18
EFFICIENT DESIGNS FOR THE ESTIMATION OF MIXED AND SELF CARRYOVER EFFECTS.
- Published in:
- Statistica Sinica, 2021, v. 31, n. 2, p. 1081, doi. 10.5705/ss.202018.0137
- By:
- Publication type:
- Article
19
Technical Efficiency of Indian Pharmaceutical Firms: A Stochastic Frontier Function Approach.
- Published in:
- Productivity, 2013, v. 54, n. 1, p. 54
- By:
- Publication type:
- Article
20
An Indian Path to Biocapital? The Traditional Knowledge Digital Library, Drug Patents, and the Reformulation Regime of Contemporary Ayurveda.
- Published in:
- East Asian Science, Technology & Society, 2014, v. 8, n. 4, p. 391, doi. 10.1215/18752160-2717469
- By:
- Publication type:
- Article
21
Compulsory licensing of chronic disease pharmaceuticals in Thailand.
- Published in:
- Thai Journal of Pharmaceutical Sciences, 2013, v. 37, n. 2, p. 61
- By:
- Publication type:
- Article
22
Putting Theory into Practice at BridgeBio.
- Published in:
- Journal of Commercial Biotechnology, 2021, v. 26, n. 2, p. 48, doi. 10.5912/jcb991
- By:
- Publication type:
- Article
23
Proposal for an Innovating Business Model for Supporting Biotechnology Companies, Ecosystem and Their Founders.
- Published in:
- Journal of Commercial Biotechnology, 2018, v. 24, n. 3, p. 6, doi. 10.5912/jcb820
- By:
- Publication type:
- Article
24
Product Hopping.
- Published in:
- Journal of Commercial Biotechnology, 2017, v. 23, n. 2, p. 52, doi. 10.5912/jcb795
- By:
- Publication type:
- Article
25
Intellectual Property Business Models Using Patent Acquisition: A Case Study of Royalty Pharma Inc.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
26
The Globetrotting Regulator.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
27
The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
28
Dynamic Evaluation of Transformation Ability for Emergency Scientific Research Achievements Based on an Improved Minimum Distance-Maximum Entropy Combination Weighting Method: A Case Study of COVID-19 Epidemic Data.
- Published in:
- Computational Intelligence & Neuroscience, 2022, p. 1, doi. 10.1155/2022/8005249
- By:
- Publication type:
- Article
29
ON THE APPEAL OF DRUG PATENT CHALLENGES.
- Published in:
- American University Law Review, 2023, v. 72, n. 4, p. 1133
- By:
- Publication type:
- Article
30
Accord could make Canadian generics industry a 'rust bucket'.
- Published in:
- Nature Medicine, 2012, v. 18, n. 7, p. 991, doi. 10.1038/nm0712-991b
- By:
- Publication type:
- Article
31
EU court gets tough on patent extensions for combo products.
- Published in:
- Nature Medicine, 2012, v. 18, n. 1, p. 4, doi. 10.1038/nm0112-4b
- By:
- Publication type:
- Article
32
Health-seeking Behavior among Mothers of Under-five Children in Sokoto Metropolis, Sokoto, Nigeria.
- Published in:
- Annals of African Medicine, 2024, v. 23, n. 3, p. 335, doi. 10.4103/aam.aam_112_23
- By:
- Publication type:
- Article
33
Paucity of intellectual property rights information in the US biologics system a decade after passage of the Biosimilars Act.
- Published in:
- PLoS Medicine, 2024, v. 21, n. 4, p. 1, doi. 10.1371/journal.pmed.1004381
- By:
- Publication type:
- Article
34
PHARMACEUTICAL; TRADEMARK; PATENTS; NEWS.
- Published in:
- Journal of Generic Medicines, 2022, v. 18, n. 2, p. 116, doi. 10.1177/17411343221097251
- By:
- Publication type:
- Article
35
Recognizing barriers to entry of biosimilars in the United States market and highlighting the solutions.
- Published in:
- Journal of Generic Medicines, 2021, v. 17, n. 3, p. 122, doi. 10.1177/1741134320972155
- By:
- Publication type:
- Article
36
EU Legal and Regulatory Update.
- Published in:
- Journal of Generic Medicines, 2022, v. 18, n. 1, p. 56, doi. 10.1177/17411343221081718
- By:
- Publication type:
- Article
37
Pharmaceutical; Trademark; Patents; News.
- Published in:
- Journal of Generic Medicines, 2021, v. 17, n. 3, p. 157, doi. 10.1177/17411343211022969
- By:
- Publication type:
- Article
38
Authorized generics vs. branded generics: A perspective.
- Published in:
- Journal of Generic Medicines, 2021, v. 17, n. 1, p. 5, doi. 10.1177/1741134320947773
- By:
- Publication type:
- Article
39
The effect of patent expiration on sales of branded competitor drugs in a therapeutic class.
- Published in:
- Journal of Generic Medicines, 2019, v. 15, n. 4, p. 177, doi. 10.1177/1741134319856408
- By:
- Publication type:
- Article
40
Pharmaceutical; Trademark; Patents; News.
- Published in:
- Journal of Generic Medicines, 2019, v. 15, n. 2, p. 80, doi. 10.1177/1741134319849255
- By:
- Publication type:
- Article
41
Evergreening of pharmaceutical patents: A blithe disregard for the rationale of the patent system.
- Published in:
- Journal of Generic Medicines, 2019, v. 15, n. 2, p. 53, doi. 10.1177/1741134319848797
- By:
- Publication type:
- Article
42
Pharmaceutical; Trademark; Patents; News.
- Published in:
- Journal of Generic Medicines, 2018, v. 14, n. 3, p. 141, doi. 10.1177/1741134318776412
- By:
- Publication type:
- Article
43
Pharmaceutical; Trademark; Patents; News.
- Published in:
- Journal of Generic Medicines, 2018, v. 14, n. 2, p. 89, doi. 10.1177/1741134318755430
- By:
- Publication type:
- Article
44
Latest Top 20 Read Articles.
- Published in:
- Journal of Generic Medicines, 2018, v. 14, n. 1, p. 48, doi. 10.1177/1741134318762726
- Publication type:
- Article
45
The curious case of India’s Bolar provision.
- Published in:
- Journal of Generic Medicines, 2018, v. 14, n. 1, p. 16, doi. 10.1177/1741134317745351
- By:
- Publication type:
- Article
46
Impact of generic entry to off-patent branded medicines in Japanese pharmaceutical market.
- Published in:
- Journal of Generic Medicines, 2017, v. 13, n. 3, p. 114, doi. 10.1177/1741134317698194
- By:
- Publication type:
- Article
47
Latest Top 20 Read Articles.
- Published in:
- Journal of Generic Medicines, 2017, v. 13, n. 4, p. 222, doi. 10.1177/1741134317744499
- Publication type:
- Article
48
Do innovative activities matter to Indian drug and pharmaceutical firms? An application to export performance.
- Published in:
- Journal of Generic Medicines, 2017, v. 13, n. 4, p. 193, doi. 10.1177/1741134317716221
- By:
- Publication type:
- Article
49
Editorial.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
50
8399514 Update: IPRs Involving Biotech and Pharmaceutical Patents.
- Published in:
- Journal of Generic Medicines, 2017, v. 13, n. 3, p. 137, doi. 10.1177/1741134317694483
- By:
- Publication type:
- Article